RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients

Author:

Golan Talia1,Khvalevsky Elina Zorde2,Hubert Ayala3,Gabai Rachel Malka2,Hen Naama2,Segal Amiel4,Domb Abraham5,Harari Gil6,David Eliel Ben7,Raskin Stephen1,Goldes Yuri1,Goldin Eran8,Eliakim Rami1,Lahav Maor1,Kopleman Yael9,Dancour Alain8,Shemi Amotz2,Galun Eithan10

Affiliation:

1. The Sackler School of Medicine, The Chaim Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel

2. Silenseed Ltd., Jerusalem, Israel

3. Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

4. The Gastroenterology Institute, Shaare Zedek Medical Centre, Jerusalem, Israel

5. Institute of Drug Research, School of Pharmacy-Faculty of Medicine, Center for Nanoscience and Nanotechnology and The Alex Grass Centre for Drug Design and Synthesis, The Hebrew University of Jerusalem, Jerusalem, Israel

6. MediStat Ltd., Jerusalem, Israel

7. Hadassah-Hebrew University Medical Centre, Jerusalem, Israel

8. The Gastroenterology Institute, Shaare Zedek Medical Center, Jerusalem, Israel

9. Gastroenterology Institute, Hadassah Hebrew University Medical Center, Jerusalem, Israel

10. The Goldyne Savad Institute for Gene Therapy, Hadassah Hebrew University Medical Center, Jerusalem, Israel

Publisher

Impact Journals, LLC

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3